A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials

Moka Komaki, Satoru Shinoda, Haiyan Zheng +1

It is crucial to design Phase II cancer clinical trials that balance the efficiency of treatment selection with clinical practicality. Sargent and Goldberg proposed a frequentist d…